HC Wainwright & Co. Reiterates Neutral on CytoSorbents, Maintains $1 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Sean Lee has reiterated a Neutral rating on CytoSorbents (NASDAQ:CTSO) and maintained a $1 price target.
August 14, 2024 | 12:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
HC Wainwright & Co. analyst Sean Lee has reiterated a Neutral rating on CytoSorbents and maintained a $1 price target.
The reiteration of a Neutral rating and maintenance of a $1 price target suggests that the analyst does not foresee significant short-term changes in the stock's performance. This is likely to result in a neutral impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100